Polaris Venture Partners V, L.P. 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-07 5:05 pm Unchanged | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Polaris Venture Partners V, L.P. | 28,475 4.500% | 0 (Unchanged) | Filing |
| 2021-02-12 5:10 pm Purchase | 2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Polaris Venture Partners V, L.P. | 28,475 11.000% | 28,475 (New Position) | Filing |